Overview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa

NEW YORK, May 29, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0868600/Overview-of-the-Orphan-Diseases-and-Drugs-Space-in-Sub-Saharan-Africa.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

Research was carried out on the orphan disease and related drug space in Sub-Saharan Africa with emphasis on 5 countries, namely, Ghana, Nigeria, Uganda, Kenya and Tanzania. An analysis into the systems, treatment regimes and organisation and company involvement and their interrelations was carried out. Each country's status, with respect to these analyses results, was ascertained. Market dynamics, including challenges, drivers and restraints, were also identified along with potential involvement opportunities.

Research Aim and Objectives Slide 17

Research Scope, Definitions and Exchange Rates Slide 19

Research Methodology Slide 23

Orphan Drugs and Diseases in Sub-Saharan AfricaAn Introduction Slide 25

Definition of an Orphan Disease Slide 26

Neglected Tropical DiseasesAn Overview Slide 27

Rare DiseasesAn Overview Slide 28

More here:
Overview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa